Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707161 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma
A Phase 2 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00707161: Clinical Trial Phase 2 study, sponsored by University of Utah.
NCT00707161 is a Phase 2 study that was terminated before completion, run by University of Utah. The registered enrollment target is 6 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00707161, a Phase 2 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The study is a prospective phase II trial of radiation therapy concurrent with cisplatin chemotherapy in the treatment of locally advanced or metastatic melanoma in patients who are deemed to require radiation therapy by treating physicians for purposes of local control or palliation. Eligibility criteria include pathologically confirmed melanoma. Patients will undergo radiation therapy (20 treatments of 2.5 Gy for a total of 50 Gy) concurrent with cisplatin chemotherapy.
Primary Outcome
Response rate of melanoma lesions was measured after treated with the trial agent.
Interventions
- DRUG Cisplatin
- RADIATION Radiation Therapy
- PROCEDURE Surgical resection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2005-09 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Why NCT00707161 stopped before completion
NCT00707161 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Cisplatin is the first listed.
NCT00707161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00707161 about?
NCT00707161 is a clinical study titled "Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma". The study is a prospective phase II trial of radiation therapy concurrent with cisplatin chemotherapy in the treatment of locally advanced or metastatic melanoma in patients who are deemed to require radiation therapy by treating physicians for purposes of local control or palliation. Eligibility cr...
What is the current status of trial NCT00707161?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2005-09. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00707161?
The interventions under investigation include: Cisplatin (DRUG), Radiation Therapy (RADIATION), Surgical resection (PROCEDURE).
Who is sponsoring clinical trial NCT00707161?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00707161's enrollment target sits among peer trials
6 1996th of 2000 higher than 1 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia